CytoDyn Inc. Files Q1 2026 10-Q Report
Ticker: CYDY · Form: 10-Q · Filed: 2026-04-08T08:30:28-04:00
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
CYDY filed its 10-Q for Feb 28, 2026. Standard quarterly update.
AI Summary
CytoDyn Inc. filed its quarterly report (10-Q) on April 8, 2026, for the period ending February 28, 2026. The filing includes various exhibits such as the 10-Q itself, financial statements, and certifications. The company's mailing and business address is 1111 Main Street, Suite 660, Vancouver, WA 98660.
Why It Matters
This filing provides investors with an update on CytoDyn Inc.'s financial performance and operational status for the most recent quarter, crucial for investment decisions.
Risk Assessment
Risk Level: low — This filing is a routine quarterly report and does not contain inherently high-risk information.
Key Numbers
- 1989560 — 10-Q Document Size (Size of the main 10-Q filing in bytes.)
- 7809994 — Complete Submission Text File Size (Total size of the complete submission text file in bytes.)
Key Players & Entities
- CytoDyn Inc. (company) — Filer of the 10-Q report
- 0001175680 (company) — CIK number for CytoDyn Inc.
- 2026-04-08 (date) — Filing date of the 10-Q
- 2026-02-28 (date) — Period of report for the 10-Q
- 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 (location) — Mailing and business address of CytoDyn Inc.
FAQ
What is the primary document filed by CytoDyn Inc. on April 8, 2026?
CytoDyn Inc. filed a Form 10-Q, a quarterly report, on April 8, 2026.
What period does this 10-Q filing cover?
The period of report for this 10-Q filing is February 28, 2026.
What is CytoDyn Inc.'s CIK number?
CytoDyn Inc.'s CIK number is 0001175680.
Where is CytoDyn Inc. located based on the filing?
CytoDyn Inc.'s mailing and business address is 1111 Main Street, Suite 660, Vancouver, WA 98660.
What is the size of the iXBRL 10-Q document?
The iXBRL 10-Q document (cydy-20260228x10q.htm) has a size of 1989560 bytes.
From the Filing
EDGAR Filing Documents for 0001104659-26-040687 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 10-Q - Quarterly report [Sections 13 or 15(d)]: SEC Accession No. 0001104659-26-040687 Filing Date 2026-04-08 Accepted 2026-04-08 08:30:28 Documents 69 Period of Report 2026-02-28 Interactive Data Document Format Files Seq Description Document Type Size 1 10-Q cydy-20260228x10q.htm iXBRL 10-Q 1989560 2 EX-10.1 cydy-20260228xex10d1.htm EX-10.1 78172 3 EX-10.2 cydy-20260228xex10d2.htm EX-10.2 85832 4 EX-31.1 cydy-20260228xex31d1.htm EX-31.1 9244 5 EX-31.2 cydy-20260228xex31d2.htm EX-31.2 9390 6 EX-32 cydy-20260228xex32.htm EX-32 7680 Complete submission text file 0001104659-26-040687.txt 7809994 Data Files Seq Description Document Type Size 7 EX-101.SCH cydy-20260228.xsd EX-101.SCH 58591 8 EX-101.CAL cydy-20260228_cal.xml EX-101.CAL 48288 9 EX-101.DEF cydy-20260228_def.xml EX-101.DEF 212843 10 EX-101.LAB cydy-20260228_lab.xml EX-101.LAB 409178 11 EX-101.PRE cydy-20260228_pre.xml EX-101.PRE 339165 73 EXTRACTED XBRL INSTANCE DOCUMENT cydy-20260228x10q_htm.xml XML 1358304 Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524 CytoDyn Inc. (Filer) CIK : 0001175680 (see all company filings) EIN. : 753056237 | State of Incorp.: DE | Fiscal Year End: 0531 Type: 10-Q | Act: 34 | File No.: 000-49908 | Film No.: 26846579 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)